Switch View
© PR Newswire
29.09.2025
ISIN: US9224751084
Veeva Systems Inc
VEEV
LISTED
NYSE
Branchenstudie: Zwei Drittel der klinischen Datenmanager und CRAs glauben, dass aktuelle Ineffizienzen die Datenqualität in Zukunft gefährden
News Preview
Aus dem Bericht geht hervor, dass jeder Datenverwalter für den manuellen Datenabgleich, die Datenbereinigung sowie die Überprüfung mehr als 12 Stunden pro Woche und Studie benötigt.
BARCELONA, Spanien, 29. September 2025 /PRNewswire/ -- Zwei Drittel der Datenman...
Themefolio
Profiler
Peergroup
© BusinessWire
29.09.2025
ISIN: US5165441032
Lantheus Holdings Inc
LNTH
LISTED
NASDAQ
Johnson Fistel Announces Class Action Lawsuit Against Lantheus Holdings, Inc. (LNTH) on Behalf of Investors
News Preview
Johnson Fistel, PLLP announces that a class action lawsuit has commenced on behalf of investors of Lantheus Holdings, Inc. (NASDAQ: LNTH). The lawsuit seeks to recover losses on behalf of investors who purchased the Company’s securities between February 26, 2025 and August 5, 2025, inclusive (the “Class Period”).
What if I purchased Lantheus sec...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.09.2025
ISIN: US0327241065
AnaptysBio Inc
ANAB
LISTED
NASDAQ
Anaptys Announces Intent to Separate Biopharma Operations from Substantial Royalty Assets by Year-end 2026
News Preview
SAN DIEGO, Sept. 29, 2025 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, announced today that its Board of Directors approved plans to explore separating its business into two independent, publicly traded companies, each poised for strong, susta...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© Globe Newswire
29.09.2025
ISIN: US0327241065
AnaptysBio Inc
ANAB
LISTED
NASDAQ
Anaptys to Provide Overview of ANB033, a CD122 antagonist, at Virtual Investor Event on Tuesday, Oct. 14
News Preview
SAN DIEGO, Sept. 29, 2025 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today announced it will host a virtual investor event on ANB033, its CD122 antagonist, at 4:30pm ET / 1:30pm PT on Tuesday, Oct. 14....
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© Globe Newswire
29.09.2025
ISIN: NL0010696654
Uniqure NV
QURE
LISTED
NASDAQ
uniQure Announces Closing of Upsized Public Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares
News Preview
LEXINGTON, Mass. and AMSTERDAM, Sept. 29, 2025 (GLOBE NEWSWIRE) -- uniQure N.V. (Nasdaq: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced the closing of its previously announced underwritten public offering of 6,736,841 ordinary shares at a public offering price of $4...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.09.2025
ISIN: US9032141049
Cogent Biosciences, Inc.
COGT
LISTED
NASDAQ
Cogent Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
WALTHAM, Mass. and BOULDER, Colo., Sept. 29, 2025 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced that on September 25, 2025, the Compensation Committee of Cogent’s Board of Directors, made up entirely of independent di...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.09.2025
ISIN: US4525253062
ImmuCell Corporation
ICCC
LISTED
NASDAQ
ImmuCell Announces Selection of its Next President and CEO
News Preview
PORTLAND, Maine, Sept. 29, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the health and productivity of dairy and beef cattle, today announced that it has selected Olivier...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.09.2025
ISIN: US59267L1070
Metsera, Inc.
MTSR
LISTED
NASDAQ
Metsera Reports Positive Phase 2b Results for First- and Best-in-Class Ultra-long Acting GLP-1 RA Candidate MET-097i, Enabling Rapid Transition into Phase 3
News Preview
Placebo-subtracted mean weight loss up to 14.1% after 28 weeks with no plateau...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.09.2025
ISIN: US81734D1046
Septerna, Inc.
SEPN
LISTED
NASDAQ
Septerna Appoints Veteran Biotechnology Leader Keith Gottesdiener, M.D., to its Board of Directors
News Preview
SOUTH SAN FRANCISCO, Calif., Sept. 29, 2025 (GLOBE NEWSWIRE) -- Septerna, Inc. (NASDAQ: SEPN), a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) drug discovery, today announced the appointment of Keith Gottesdiener, M.D., to its board of directors. A seasoned biotechnology executive with over 30 year...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.09.2025
ISIN: US50127T1097
Kura Oncology Inc
KURA
LISTED
NASDAQ
Kura Oncology and Kyowa Kirin Announce First Patient Dosed in Pivotal Phase 3 KOMET-017 Trial of Ziftomenib for Frontline Acute Myeloid Leukemia (AML)
News Preview
– KOMET-017-IC trial of intensive chemotherapy combination will assess MRD negative CR and EFS as dual-primary endpoints to support potential U.S. accelerated and full approval –...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.09.2025
ISIN: US03969K1088
Arcutis Biotherapeutics Inc
ARQT
LISTED
NASDAQ
Arcutis Biotherapeutics to Host Virtual Investor Day and Report Third Quarter 2025 Financial Results on October 28, 2025
News Preview
Arcutis today announced that it will report Q3 2025 financial results and host a virtual Investor Day on Tuesday, October 28, 2025....
Themefolio
Profiler
Peergroup
© PR Newswire
29.09.2025
ISIN: US53216B1044
LifeMD, Inc.
LFMD
LISTED
NASDAQ
SHAREHOLDER ALERT: Berger Montague Reminds LifeMD, Inc. (NASDAQ: LFMD) Investors of Class Action Lawsuit Deadline
News Preview
PHILADELPHIA, Sept. 29, 2025 /PRNewswire/ -- National plaintiffs' law firm Berger Montague PC announces a class action lawsuit against LifeMD, Inc. (NASDAQ: LFMD) ("LifeMD" or the "Company") on behalf of investors who purchased or acquired shares during the period from May 7, 2025 through August 5, 2025 (the "Cla...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© ActuNews
29.09.2025
ISIN: FR0013286259
Theranexus SA
ALTHX
LISTED
EURONEXT
Theranexus devient THX Pharma : une évolution stratégique vers la commercialisation de ses médicaments dans les maladies rares
News Preview
Avec TX01 et Batten-1, THX Pharma ouvre une nouvelle phase stratégique tournée vers l'enregistrement, l'accès précoce et la commercialisation internationale de ses médicaments.
Lyon, France – 29 septembre 2025, 6.30 pm CEST – THX Pharma (Theranexus), société pharmaceutique sp&eacu...
Themefolio
Profiler
Peergroup
© ActuNews
29.09.2025
ISIN: FR0013286259
Theranexus SA
ALTHX
LISTED
EURONEXT
Theranexus Becomes THX Pharma: A Strategic Evolution Toward the Commercialization of Its Medicines for Rare Diseases
News Preview
With TX01 and Batten-1, THX Pharma is entering a new strategic phase focused on regulatory approval, early access, and international commercialization of its medicines.
Lyon, France – September 29, 2025, 6.30 pm CEST – THX Pharma (formerly Theranexus), a pharmaceutical company specializing in rare neurological diseases, today unveils it...
Themefolio
Profiler
Peergroup
© BusinessWire
29.09.2025
ISIN: KY61559X1045
MoonLake Immunotherapeutics
MLTX
LISTED
NASDAQ
MLTX INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of MoonLake Immunotherapeutics
News Preview
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against MoonLake Immunotherapeutics (“MoonLake” or the “Company”) (NASDAQ: MLTX).
Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of mill...
Themefolio
Profiler
Peergroup
© BusinessWire
29.09.2025
ISIN: US4718712023
Jasper Therapeutics, Inc.
JSPR
LISTED
NASDAQ
Deadline Alert: Jasper Therapeutics, Inc. (JSPR) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit
News Preview
Glancy Prongay & Murray LLP reminds investors of the upcoming November 18, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Jasper Therapeutics, Inc. (“Jasper” or the “Company”) (NASDAQ: JSPR) securities between November 30, 2023 and July 3, 2025, inclusive (the...
Themefolio
Profiler
Peergroup
© PR Newswire
29.09.2025
ISIN: US00287Y1091
AbbVie Inc
ABBV
LISTED
EURONEXT
AbbVie Breaks Ground on New North Chicago Active Pharmaceutical Ingredient Manufacturing Facility
News Preview
New state-of-the-art active pharmaceutical ingredient (API) facility will manufacture immunology, oncology and neuroscience medicines
Facility expected to be fully operational and serving patients by 2027...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.09.2025
ISIN: BE0003874915
Fagron NV
FAGR
LISTED
EURONEXT
Fagron increases share capital through exercise subscription rights
News Preview
Regulated informationNazareth (Belgium)/Rotterdam (The Netherlands), 29 September 2025 – 7PM CET...
Themefolio
Profiler
Peergroup
© PR Newswire
29.09.2025
ISIN: US15135B1017
Centene Corp
CNC
LISTED
NYSE
CENTENE CORPORATION TO HOST 2025 THIRD QUARTER FINANCIAL RESULTS EARNINGS CALL CALL SCHEDULED FOR 9AM ET
News Preview
ST. LOUIS, Sept. 29, 2025 /PRNewswire/ -- Centene Corporation (NYSE: CNC), a leading healthcare enterprise committed to helping people live healthier lives, announced today that it will release its 2025 third quarter financial results at approximately 6:00 a.m. ET on Wednesday, October 29, 2025, and host a confer...
Themefolio
Profiler
Peergroup
© PR Newswire
29.09.2025
ISIN: US4364401012
Hologic Inc
HOLX
LISTED
NASDAQ
Minicarm.com Named Exclusive U.S. Distributor of Hologic's Fluoroscan® Insight FD Mini C-Arm
News Preview
HAUPPAUGE, N.Y., Sept. 29, 2025 /PRNewswire/ -- Minicarm.com, a leading provider of imaging solutions for orthopedic and surgical practices, is proud to announce that it has secured an allocation of the Hologic Fluoroscan® Insight™ FD Mini C-Arm for resale in the United States. As Hologic transitions away from co...
Themefolio
Profiler
Peergroup
© PR Newswire
29.09.2025
ISIN: US2307701092
Cumberland Pharmaceuticals, Inc.
CPIX
LISTED
NASDAQ
TABUK LAUNCHES VIBATIV® FDA-APPROVED ANTIBIOTIC WITH LIFE-SAVING POTENTIAL IN SAUDI ARABIA
News Preview
Vibativ
®
treats patients with pneumonia and serious skin infections
NASHVILLE, Tenn. and RIYADH, Saudi Arabia, Sept. 29, 2025 /PRNewswire/ -- Specialty pharmaceutical companies Tabuk Pharmaceutical Manufacturing Company a fu...
Themefolio
Profiler
Peergroup
© BusinessWire
29.09.2025
ISIN: JP3801300009
Phc Holdings Corp.
65230
LISTED
XJPX
Epredia’s E1000 Dx Digital Pathology Solution Wins 2025 International Scanner Benchmark Awards from the Ecosystem for Pathology Diagnostics with AI Assistance (EMPAIA)
News Preview
The Ecosystem for Pathology Diagnostics with AI Assistance (EMPAIA), an international organization that advances the use of validated AI solutions in clinical practice, has announced that Epredia, a global leader in precision cancer diagnostics, has won three categories in the 2025 International Scanner Benchmark (ISB) for Epredia’s E1000 Dx Digit...
Themefolio
Profiler
Peergroup
© PR Newswire
29.09.2025
ISIN: US00287Y1091
AbbVie Inc
ABBV
LISTED
EURONEXT
AbbVie Announces UK Pricing Strategy for ELAHERE® (mirvetuximab soravtansine-gynx)
News Preview
The list price will be consistent with the United States to reflect the value of the innovation
AbbVie is committed to ensuring that developed nations fully recognize the value of our medicines in improving patient outcomes, consistent...
Themefolio
Profiler
Peergroup
© BusinessWire
29.09.2025
ISIN: FR0014000MR3
Eurofins Scientific SE
ERF
LISTED
EURONEXT
Eurofins Scientific: Director/PDMR Shareholding
News Preview
Eurofins Scientific SE (EUFI.PA) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below.
This notification is made in accordance with the European Market Abuse Regulation.
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS...
Themefolio
Profiler
Peergroup
© PR Newswire
29.09.2025
ISIN: US23282W6057
Cytokinetics Inc
CYTK
LISTED
NASDAQ
Class Action Filed Against Cytokinetics, Incorporated (CYTK) Seeking Recovery for Investors - Contact The Gross Law Firm
News Preview
NEW YORK, Sept. 29, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Cytokinetics, Incorporated (NASDAQ: CYTK).
Shareholder...
Themefolio
Profiler
Peergroup
© PR Newswire
29.09.2025
ISIN: US5165441032
Lantheus Holdings Inc
LNTH
LISTED
NASDAQ
The Gross Law Firm Notifies Shareholders of Lantheus Holdings, Inc.(LNTH) of a Class Action Lawsuit and an Upcoming Deadline
News Preview
NEW YORK, Sept. 29, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Lantheus Holdings, Inc. (NASDAQ: LNTH).
Shareholders w...
Themefolio
Profiler
Peergroup
© PR Newswire
29.09.2025
ISIN: US53216B1044
LifeMD, Inc.
LFMD
LISTED
NASDAQ
Investors in LifeMD, Inc. Should Contact The Gross Law Firm Before October 25, 2025 to Discuss Your Rights - LFMD
News Preview
NEW YORK, Sept. 29, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of LifeMD, Inc. (NASDAQ: LFMD).
Shareholders who purchase...
Themefolio
Profiler
Peergroup
© PR Newswire
29.09.2025
ISIN: US8051111016
Savara Inc
SVRA
LISTED
NASDAQ
The Gross Law Firm Reminds Savara Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of November 7, 2025 - SVRA
News Preview
NEW YORK, Sept. 29, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Savara Inc. (NASDAQ: SVRA).
Shareholders who purchased...
Themefolio
Profiler
Peergroup
© PR Newswire
29.09.2025
ISIN: US02155H1014
Altimmune, Inc.
ALT
LISTED
NASDAQ
Shareholders that lost money on Altimmune, Inc.(ALT) should contact The Gross Law Firm about pending Class Action - ALT
News Preview
NEW YORK, Sept. 29, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Altimmune, Inc. (NASDAQ: ALT).
Shareholders who purcha...
Themefolio
Profiler
Peergroup
© PR Newswire
29.09.2025
ISIN: US81684M1045
Semler Scientific Inc
SMLR
LISTED
NASDAQ
Shareholders of Semler Scientific, Inc. Should Contact The Gross Law Firm Before October 28, 2025 to Discuss Your Rights - SMLR
News Preview
NEW YORK, Sept. 29, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Semler Scientific, Inc. (NASDAQ: SMLR).
Shareholders w...
Themefolio
Profiler
Peergroup
© PR Newswire
29.09.2025
ISIN: US67079U3068
Nutex Health Inc
NUTX
LISTED
NASDAQ
Class Action Filed Against Nutex Health Inc. (NUTX) Seeking Recovery for Investors - Contact The Gross Law Firm
News Preview
NEW YORK, Sept. 29, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Nutex Health Inc. (NASDAQ: NUTX).
Shareholders who pur...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.09.2025
ISIN: DK0015998017
Bavarian Nordic A/S
BAVA
LISTED
CPH
Consortium consisting of Nordic Capital and Permira extends offer period until 14 October 2025 and provides update on regulatory approvals in respect of the takeover offer to the shareholders of Bavarian Nordic
News Preview
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION...
Themefolio
Profiler
Peergroup
© BusinessWire
29.09.2025
ISIN: US8753722037
Tandem Diabetes Care Inc
TNDM
LISTED
NASDAQ
Tandem t:slim X2 Insulin Pump Now Compatible With Lyumjev Ultra-Rapid Acting Insulin in the United States
News Preview
Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that its t:slim X2™ insulin pump with Control-IQ+ automated insulin delivery (AID) technology is now cleared for use with Eli Lilly and Company’s Lyumjev® (insulin lispro-aabc injection) ultra-rapid acting insulin in the United St...
Themefolio
Profiler
Peergroup
© Newsfile
29.09.2025
ISIN: CA09073K1084
Biomark Diagnostics Inc.
BUX
LISTED
CSE
BioMark Secures Key Patents in Asia's Largest Markets for Early Lung Cancer Liquid Biopsy
News Preview
Pioneering liquid biopsy platform for early lung cancer detection strengthens IP and accelerates commercial strategy in China and Japan diagnostic markets.Vancouver, British Columbia--(Newsfile Corp. - September 29, 2025) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTCQB: BMKDF) ("BioMark"), a leading developer of liquid biopsy technolog...
Themefolio
Profiler
Peergroup
© PR Newswire
29.09.2025
ISIN: IE00BTN1Y115
Medtronic PLC
MDT
LISTED
NYSE
Medtronic Announces Closing of Public Offering of €1.5 Billion of Senior Notes
News Preview
GALWAY, Ireland, Sept. 29, 2025 /PRNewswire/ -- Medtronic plc (the "Company") (NYSE: MDT) announced today that its wholly-owned indirect subsidiary, Medtronic, Inc., has closed a registered public offering (the "Offering") of €750,000,000 principal amount of 2.950% senior notes due 2030 and €750,000,000 principal...
Themefolio
Profiler
Peergroup
© BusinessWire
29.09.2025
ISIN: US00846U1016
Agilent Technologies Inc
A
LISTED
NYSE
Agilent Introduces the Altura Line of Inert HPLC Columns for Superior Results in Biotherapeutic Testing
News Preview
Agilent Technologies Inc. (NYSE: A) today announced the release of a new range of high performance liquid chromatography (HPLC) columns ideally suited for biotherapeutics applications. The Agilent Altura Ultra Inert HPLC Columns set a new standard in liquid chromatography performance, providing the reliability and efficiency biopharmaceutical comp...
Themefolio
Profiler
Peergroup
© BusinessWire
29.09.2025
ISIN: US6323071042
Natera Inc
NTRA
LISTED
NASDAQ
Signatera™ Surveillance Testing Identified 100% of Uterine Cancer Recurrences in Advance of Imaging, New Study Shows
News Preview
Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced the publication of a new study in the Journal of Clinical Oncology Precision Oncology (JCO PO), validating Signatera for recurrence monitoring and treatment response assessment in patients with early-stage uterine cancer.
Uterine cancer is the m...
Themefolio
Profiler
Peergroup
© BusinessWire
29.09.2025
ISIN: US7140461093
Revvity Inc
RVTY
LISTED
NYSE
Revvity Unveils New AI Software Offering to Transform Preclinical Imaging Analysis
News Preview
Today Revvity, Inc. (NYSE: RVTY), announced the launch of its Living Image™ Synergy AI multimodal analysis software for in vivo imaging researchers. The solution provides a unified platform with AI capabilities for seamless data analysis across optical, microCT, ultrasound, and other modalities—reducing data inconsistencies, streamlining workflows...
Themefolio
Profiler
Peergroup
© PR Newswire
29.09.2025
ISIN: US4781601046
Johnson & Johnson
JNJ
LISTED
NYSE
U.S. FDA approves TREMFYA® (guselkumab) for the treatment of pediatric plaque psoriasis and active psoriatic arthritis, marking a first and only approval for an IL-23 inhibitor
News Preview
TREMFYA® is now approved for pediatric patients living with moderate to severe plaque psoriasis, who are candidates for systemic therapy or phototherapy, and active psoriatic arthritis in children six years and older, weighing at least 40 kg
Approval was based...
Themefolio
Profiler
Peergroup
© PR Newswire
29.09.2025
ISIN: US0028241000
Abbott Laboratories
ABT
LISTED
NYSE
Abbott's Dissolving Stent Receives Health Canada Approval for Treating Blocked Arteries Below-the-Knee
News Preview
More than 800,000 Canadians1 live with peripheral artery disease (PAD) with limited treatment options to date1
The first-of-its-kind dissolvable stent, the Esprit™ BTK Everolimus Eluting Resorbable Scaffold, dissolves over time after it has opened blocked arteries below-the-knee (BTK)...
Themefolio
Profiler
Peergroup
© PR Newswire
29.09.2025
ISIN: CA09076M2004
BioVaxys Technology Corp.
BIOV
LISTED
CSE
BioVaxys and Horizon Technology Finance Corp Execute Amendment to Asset Purchase Agreement ("APA")
News Preview
The APA Formalized the February 2024 BioVaxys Acquisition of the Former IMV Inc. Assets
VANCOUVER, BC, Sept. 29, 2025 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) ("BioVaxys" or the "Company") is pleased to announce today that the Company and Horizo...
Themefolio
Profiler
Peergroup
© PR Newswire
29.09.2025
ISIN: CA09076M2004
BioVaxys Technology Corp.
BIOV
LISTED
CSE
BioVaxys and Horizon Technology Finance Corp Execute Amendment to Asset Purchase Agreement ("APA")
News Preview
The APA Formalized the February 2024 BioVaxys Acquisition of the Former IMV Inc. Assets
VANCOUVER, BC, Sept. 29, 2025 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) ("BioVaxys" or the "Company") is pleased to announce today that the Company and...
Themefolio
Profiler
Peergroup
© PR Newswire
29.09.2025
ISIN: US22407B1089
Coya Therapeutics, Inc.
COYA
LISTED
NASDAQ
Coya Therapeutics Announces Completion of Patient Enrollment of an Investigator-Initiated, Open-Label Study with Low-Dose IL-2 and CTLA4-Ig Combination Treatment in Patients with Mild to Moderate Frontotemporal Dementia
News Preview
Following the positive interim results in 5 patients announced earlier this year, a total of 9 patients have been enrolled as planned
The study is progressing according to protocol, and no safety issues have been reported...
Themefolio
Profiler
Peergroup
© PR Newswire
29.09.2025
ISIN: US75901B1070
Regenxbio Inc
RGNX
LISTED
NASDAQ
REGENXBIO Announces Presentation at the World Muscle Society
News Preview
ROCKVILLE, Md., Sept. 29, 2025 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced Chief Medical Officer, Steve Pakola, M.D., will present at the International Congress of the World Muscle Society taking place in Vienna, Austria, October 7-11, 2025.
The podium presentation will share new...
Themefolio
Profiler
Peergroup
© PR Newswire
29.09.2025
ISIN: US9224751084
Veeva Systems Inc
VEEV
LISTED
NYSE
Industry Research Finds Two-Thirds of Clinical Data Managers and CRAs Believe Current Inefficiencies Put Data Quality at Future Risk
News Preview
Report shows completing manual data reconciliation, cleaning, and review takes each data manager more than 12 hours per week, per study
BALTIMORE, Sept. 29, 2025 /PRNewswire/ -- SCDM 2025 — Two-thirds of data managers and clinical research associates (CRAs) repo...
Themefolio
Profiler
Peergroup
© PR Newswire
29.09.2025
ISIN: US9224751084
Veeva Systems Inc
VEEV
LISTED
NYSE
Industry Research Finds Two-Thirds of Clinical Data Managers and CRAs Believe Current Inefficiencies Put Data Quality at Future Risk
News Preview
Report shows completing manual data reconciliation, cleaning, and review takes each data manager more than 12 hours per week, per study
BARCELONA, Spain, Sept. 29, 2025 /PRNewswire/ -- Two-thirds of data managers and clinical research associates (CRAs) report th...
Themefolio
Profiler
Peergroup
© BusinessWire
29.09.2025
ISIN: CA74040N1069
Predictmedix AI Inc
PMED
LISTED
CSE
Predictmedix AI to Present at the 25th MK Investment Conference in Munich, Germany
News Preview
Predictmedix AI Inc. (CSE: PMED) (OTC: PMEDF) (FRA: 3QP0) (“Predictmedix” or the “Company”), an emerging leader in AI-powered health and safety technology, is pleased to announce that its Chief Operating Officer and Co-founder, Dr. Rahul Kushwah, will be presenting at the prestigious 25th MK Investment Conference in Munich, Germany, on October 1,...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.09.2025
ISIN: US76155X1000
Revolution Medicines Inc
RVMD
LISTED
NASDAQ
Revolution Medicines Announces Key Leadership Additions, including Alan Sandler, M.D. as Chief Development Officer
News Preview
REDWOOD CITY, Calif., Sept. 29, 2025 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced the appointment of Alan Sandler, M.D. into the newly created role of chief development officer, as well as the appointment...
Themefolio
Profiler
Peergroup
© PR Newswire
29.09.2025
ISIN: US23283X2062
Cytosorbents Corp
CTSO
LISTED
NASDAQ
CytoSorbents to Showcase Pioneering New Cardiac Surgery Data in Key Applications at the EACTS 2025 Annual Meeting in Copenhagen
News Preview
PRINCETON, N.J., Sept. 29, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, announced today its strong scientific presence at the upcoming European Association for Cardio-...
Themefolio
Profiler
Peergroup
© BusinessWire
29.09.2025
ISIN: NL0011606264
Merus N.V.
MRUS
LISTED
NASDAQ
MRUS Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Merus N.V. Is Fair to Shareholders
News Preview
Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Merus N.V. (NASDAQ: MRUS) to Genmab A/S for $97.00 per share is fair to Merus shareholders.
Halper Sadeh encourages Merus shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.09.2025
ISIN: IL0011316309
Mediwound Ltd
MDWD
LISTED
NASDAQ
MediWound Announces $30 Million Registered Direct Offering of Ordinary Shares
News Preview
MediWound Announces $30 Million Registered Direct Offering of Ordinary Shares...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.09.2025
ISIN: US26818M1080
Dyne Therapeutics Inc
DYN
LISTED
NASDAQ
Dyne Therapeutics Receives Orphan Drug Designation in Japan for DYNE-251 in Duchenne Muscular Dystrophy
News Preview
- Data from ongoing DELIVER trial demonstrated sustained functional improvement through 18 months; results from Registrational Expansion Cohort expected late 2025 -...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
29.09.2025
ISIN: US36257K2087
Marijuana Inc.
MAJI
LISTED
OTC
Exousia Pro Announces Groundbreaking Study to Revolutionize the Global Edibles Market with CBD-Loaded Exosomes
News Preview
ORLANDO, FLORIDA / ACCESS Newswire / September 29, 2025 / Exousia Pro, Inc. (OTCPINK:MAJI), a clinical-stage biotechnology company focused on advanced exosome-based therapies, today announced its plan to conduct an Institutional Review Board (IRB) study that could fundamentally transform the cannabinoid edible and nutraceutical markets.The study is...
Themefolio
Profiler
Peergroup
© BusinessWire
29.09.2025
ISIN: US29251M1062
Enanta Pharmaceuticals Inc
ENTA
LISTED
NASDAQ
Enanta Pharmaceuticals Reports Positive Topline Results from its Phase 2b Study of Zelicapavir for the Treatment of Respiratory Syncytial Virus (RSV) in High-Risk Adults
News Preview
Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections and immunological diseases, today announced positive topline data from RSVHR, a Phase 2b, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of zelicapavir in outpat...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.09.2025
ISIN: US21900C3088
CorMedix Inc
CRMD
LISTED
NASDAQ
CorMedix Announces Completion of Enrollment in Phase III ReSPECT Clinical Trial for REZZAYO
News Preview
- Enrollment Completed in Ongoing Phase III ReSPECT Study in Prophylaxis of Fungal Infections in Adult Patients Undergoing Allogeneic Blood and Marrow Transplant -...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.09.2025
ISIN: US09073N3008
Streamex Exchange Corp.
STEX
LISTED
NASDAQ
Streamex Corp. to Participate in the Clear Street Disruptive Technology Conference on November 19-20, 2025
News Preview
LOS ANGELES, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Streamex Corp. (“Streamex” or the “Company”) (NASDAQ: STEX), a leader in institutional-grade tokenization of real-world assets, today announced the executive management team, will participate in one-to-one meetings at the Clear Street Disruptive Technology Conference at The Four Seasons Resort in Pa...
Themefolio
Profiler
Peergroup
© BusinessWire
29.09.2025
ISIN: US4448591028
Humana Inc
HUM
LISTED
NYSE
Humana Invites Everyone to Get in the Game With Pickleball Pop-Up Events
News Preview
Humana Inc. (NYSE: HUM), a leading health and well-being company, is taking pickleball on the road to celebrate their ongoing commitment to creating experiences that enable health, enhance activity, and foster connectivity.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250929806152/en...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.09.2025
ISIN: US1374041093
Candel Therapeutics, Inc.
CADL
LISTED
NASDAQ
Candel Therapeutics Presents Phase 3 Clinical Trial of CAN-2409 in Localized Prostate Cancer at ASTRO 2025
News Preview
NEEDHAM, Mass., Sept. 29, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, presented subgroup analyses focused on the radiation regimen from the Company’s positive phase 3...
Themefolio
Profiler
Peergroup
© Newsfile
29.09.2025
ISIN: CA41138T1057
Happy Belly Food Group Inc.
HBFG
LISTED
CSE
Happy Belly Food Group's Heal Wellness QSR Announces the Signing of a Franchise Agreement for Midtown Toronto, Ontario
News Preview
Toronto, Ontario--(Newsfile Corp. - September 29, 2025) - Happy Belly Food Group Inc. (CSE: HBFG) (OTCQB: HBFGF) ("Happy Belly" or the "Company"), a leader in acquiring and scaling emerging food brands is pleased to announce that Heal Wellness has signed a franchise agreement for the Yonge & Sheppard area of midtown Toronto, Ontario. Heal Welln...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.09.2025
ISIN: US2214133058
Cosmos Health Inc
COSM
LISTED
NASDAQ
Cosmos Health CEO Issues Letter to Shareholders: Building a Global Healthcare Powerhouse with $300M Digital Financing Facility, U.S. Manufacturing Expansion, and AI Innovation
News Preview
Cosmos Health CEO Issues Letter to Shareholders: Building a Global Healthcare Powerhouse with $300M Digital Financing Facility, U.S. Expansion & AI R&D...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
